# EDGAR Filing Document

**Accession Number:** 0001440132
**File Stem:** 0001193125-26-041151
**Filing Date:** 2026-2
**Character Count:** 10073
**Document Hash:** 33c388e5d1706d447696e765457c0e4b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-041151.hdr.sgml**: 20260206

**ACCESSION NUMBER**: 0001193125-26-041151

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260204

**FILED AS OF DATE**: 20260206

**DATE AS OF CHANGE**: 20260206

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Goldberg Joel S
- **CENTRAL INDEX KEY:** 0001440132

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05075
- **FILM NUMBER:** 26607561

**MAIL ADDRESS:**
- **STREET 1:** 77 4TH AVENUE
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** REVVITY, INC.
- **CENTRAL INDEX KEY:** 0000031791
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 042052042
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1229

**BUSINESS ADDRESS:**
- **STREET 1:** 77 4TH AVENUE
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
- **BUSINESS PHONE:** 781-663-6900

**MAIL ADDRESS:**
- **STREET 1:** 77 4TH AVENUE
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PERKINELMER INC
- **DATE OF NAME CHANGE:** 19991103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EG&G INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EDGERTON GERMESHAUSEN & GRIER INC
- **DATE OF NAME CHANGE:** 19670626

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Goldberg Joel S<br><sub>(Last) (First) (Middle)</sub><br>77 4TH AVENUE<br><sub>(Street)</sub><br>WALTHAM, MA 02451-7567<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-02-04 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Please See Remarks_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>REVVITY, INC. [ RVTY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-02-04 |  | F |  | 869<sup>(1)(2)</sup> | D | $101.13 | 36820 | D |  |
| Common Stock | 2026-02-04 |  | A |  | 6427<sup>(3)</sup> | A | $0 | 43247 | D |  |
| Common Stock | 2026-02-05 |  | M |  | 12717 | A | $92.09 | 55964 | D |  |
| Common Stock | 2026-02-05 |  | S<sup>(4)</sup> |  | 6424 | D | 99.47<sup>(5)</sup> | 49540 | D |  |
| Common Stock | 2026-02-05 |  | S<sup>(4)</sup> |  | 3544 | D | 100.50<sup>(6)</sup> | 45996 | D |  |
| Common Stock | 2026-02-05 |  | S<sup>(4)</sup> |  | 2217 | D | 101.33<sup>(7)</sup> | 43779 | D |  |
| Common Stock | 2026-02-05 |  | S<sup>(4)</sup> |  | 532 | D | 102.52<sup>(8)</sup> | 43247 | D |  |
| Common Stock |  |  |  |  |  |  |  | 63709 | I | By Goldberg Irrevocable 2021 Trust<sup>(9)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| NQ Stock Option (right to buy) | $103.395 | 2026-02-04 |  | A |  | 18383 |  | <sup>(10)</sup> | 2033-02-04 | Common Stock | 18383 | $0 | 18383 | D |  |
| NQ Stock Option (right to buy) | $92.09 | 2026-02-05 |  | M |  |  | 12717 | <sup>(11)</sup> | 2026-02-05 | Common Stock | 12717 | $0 | 0 | D |  |

---

### Footnotes:

(1) The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

(2) These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement.

(3) Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

(4) The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025.

(5) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.97.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

(6) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.98 to $100.95.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

(7) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.98 to $101.93.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

(8) The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03.  The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

(9) Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

(10) This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.

(11) This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.

**Remarks:**
Senior Vice President, Administration, General Counsel and Secretary

**Signature:** /s/ John L. Healy (POA on file) for Joel S. Goldberg  
**Date:** 2026-02-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**